American Association for Cancer Research (AACR) 2019 – STRO-002 Abstract 3897

Apr 11, 2019

American Association for Cancer Research (AACR) 2019

Abstract 3897: Stability and safety evaluation of STRO-002, a site-specific anti-folate receptor alpha antibody-drug conjugate for the potential treatment of ovarian and endometrial cancers.